Combination therapy for B cell disorders
Details for Australian Patent Application No. 2004251679 (hide)
International Classifications
Event Publications
12 January 2006 PCT application entered the National Phase
PCT publication WO2005/000351 Priority application(s): WO2005/000351
23 October 2008 Application Accepted
Published as AU-B-2004251679
5 February 2009 Application for Amendment
The nature of the amendment is as shown in the statement(s) filed 14 Jan 2009. Address for service in Australia - FB Rice & Co Level 23 44 Market Street Sydney NSW 2000
28 May 2009 Amendment Made
The nature of the amendment is as shown in the statement(s) filed 14 Jan 2009
4 June 2009 Standard Patent Sealed
6 January 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2004251680-Method for improving stability and shelflife of liposome complexes
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser